We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $22.2B
1-Year Est. Return 58.34%
This Fund
S&P 500
This Quarter Est. Return
+31.13%
1 Year Est. Return
+58.34%
3 Year Est. Return
+153.02%
5 Year Est. Return
+199.78%
10 Year Est. Return
+811.75%
AUM
$22.2B
AUM Growth
+$2.96B
Cap. Flow
-$534M
Cap. Flow %
-2.4%
Top 10 Hldgs %
32.73%
Holding
727
New
37
Increased
291
Reduced
287
Closed
50

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$110M
2
ENTG icon
Entegris
ENTG
+$53.1M
3
HLT icon
Hilton Worldwide
HLT
+$45.7M
4
ISRG icon
Intuitive Surgical
ISRG
+$44.3M
5
WDC icon
Western Digital
WDC
+$41.5M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$68.2M
2
JNJ icon
Johnson & Johnson
JNJ
+$67.3M
3
MSFT icon
Microsoft
MSFT
+$64.1M
4
GILD icon
Gilead Sciences
GILD
+$63.1M
5
ON icon
ON Semiconductor
ON
+$62.5M

Sector Composition

Rank Sector Weight
1 Technology 38.31%
2 Healthcare 24.36%
3 Financials 9.42%
4 Communication Services 7.08%
5 Consumer Discretionary 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAYX icon
451
Paychex
PAYX
$43.3B
$3.08M 0.01%
31,369
+5,535
+21% +$524K
THC icon
452
Tenet Healthcare
THC
$21.3B
$3.07M 0.01%
16,439
-185,719
-92% -$34.1M
KMB icon
453
Kimberly-Clark
KMB
$34.9B
$3.01M 0.01%
27,435
-111,763
-80% -$11.1M
MLM icon
454
Martin Marietta Materials
MLM
$36.6B
$2.9M 0.01%
5,035
RMD icon
455
ResMed
RMD
$32.9B
$2.89M 0.01%
14,851
+3,906
+36% +$810K
NTAP icon
456
NetApp
NTAP
$36.5B
$2.85M 0.01%
18,420
+1,347
+8% +$176K
HBAN icon
457
Huntington Bancshares
HBAN
$34.4B
$2.84M 0.01%
160,281
-12,987
-7% -$214K
ACM icon
458
Aecom
ACM
$8.57B
$2.83M 0.01%
40,592
+2,226
+6% +$170K
OXY icon
459
Occidental Petroleum
OXY
$60B
$2.8M 0.01%
57,622
+6,069
+12% +$345K
TWLO icon
460
Twilio
TWLO
$35.8B
$2.78M 0.01%
13,494
-3,039
-18% -$539K
VMC icon
461
Vulcan Materials
VMC
$34B
$2.78M 0.01%
9,418
MKC icon
462
McCormick & Company Non-Voting
MKC
$14B
$2.77M 0.01%
55,035
+5,398
+11% +$265K
CVNA icon
463
Carvana
CVNA
$53.7B
$2.76M 0.01%
41,921
-4,064
-9% -$287K
BMA icon
464
Banco Macro
BMA
$5.02B
$2.75M 0.01%
+29,700
New +$2.44M
FICO icon
465
Fair Isaac
FICO
$20.1B
$2.74M 0.01%
2,297
+102
+5% +$114K
FFIV icon
466
F5
FFIV
$22.1B
$2.73M 0.01%
6,580
+1,376
+26% +$489K
VNET
467
VNET Group
VNET
$1.81B
$2.73M 0.01%
339,875
+68,000
+25% +$617K
AIG icon
468
American International
AIG
$39.8B
$2.65M 0.01%
35,649
-264,463
-88% -$20.1M
GEN icon
469
Gen Digital
GEN
$18.3B
$2.61M 0.01%
105,016
+7,605
+8% +$170K
STN icon
470
Stantec
STN
$8.26B
$2.61M 0.01%
37,830
-976
-3% -$78.7K
SOFI icon
471
SoFi Technologies
SOFI
$23.5B
$2.61M 0.01%
145,453
-548
-0.4% -$9.28K
BPOP icon
472
Popular Inc
BPOP
$10.9B
$2.6M 0.01%
+15,862
New +$2.39M
BR icon
473
Broadridge
BR
$19.7B
$2.6M 0.01%
19,014
+2,969
+19% +$448K
LPLA icon
474
LPL Financial
LPLA
$28.3B
$2.59M 0.01%
9,210
+1,915
+26% +$575K
RF icon
475
Regions Financial
RF
$25.9B
$2.58M 0.01%
85,479
+905
+1% +$25.4K

Similar funds

Candriam SCA's Q2 2026 Portfolio in Review

As of Q2 2026, Candriam SCA held 727 positions worth $22.2B, up 15% from $19.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA's Q2 2026 filing shows 37 new, 291 increased, 287 reduced and 50 closed positions. Its largest new stake was BBVA Argentina: 1,335,000 shares worth $26.2M. The largest sale was Micron Technology, an estimated $68.2M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2026 buy was BBVA Argentina: 1,335,000 shares worth $26.2M.
  • Candriam SCA added most to Broadcom in Q2 2026, an estimated $110M increase.
  • Candriam SCA's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $68.2M.
  • Candriam SCA fully exited Ascendis Pharma A/S in Q2 2026, selling an estimated $52.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $22.2B portfolio in Q2 2026.
  • Candriam SCA opened 37 new positions and closed 50 in Q2 2026.
  • Candriam SCA's portfolio value rose 15% quarter-over-quarter to $22.2B.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.